81 FR 38217 - Sunshine Act Meeting

INTERNATIONAL TRADE COMMISSION

Federal Register Volume 81, Issue 113 (June 13, 2016)

Page Range		38217-38217
FR Document		2016-14045

Federal Register, Volume 81 Issue 113 (Monday, June 13, 2016)

[Federal Register Volume 81, Number 113 (Monday, June 13, 2016)]
[Notices]
[Page 38217]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-14045]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[USITC SE-16-019]


Sunshine Act Meeting

AGENCY HOLDING THE MEETING: United States International Trade 
Commission.

TIME AND DATE: June 16, 2016 at 11:00 a.m.

PLACE: Room 101, 500 E Street SW., Washington, DC 20436, Telephone: 
(202) 205-2000.

STATUS: Open to the public.

MATTERS TO BE CONSIDERED: 
    1. Agendas for future meetings: None.
    2. Minutes.
    3. Ratification List.
    4. Vote in Inv. No. 731-TA-1071 (Second Review) (Alloy Magnesium 
from China). The Commission is currently scheduled to complete and file 
its determination and views of the Commission on June 30, 2016.
    5. Outstanding action jackets: None.
    In accordance with Commission policy, subject matter listed above, 
not disposed of at the scheduled meeting, may be carried over to the 
agenda of the following meeting.

    By order of the Commission.

    Issued: June 8, 2016.
William R. Bishop,
Supervisory Hearings and Information Officer.
[FR Doc. 2016-14045 Filed 6-9-16; 4:15 pm]
 BILLING CODE 7020-02-P

Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices 38217

We will summarize written responses 5. Outstanding action jackets: None. DEPARTMENT OF JUSTICE
to this notice and address them in our In accordance with Commission
submission for OMB approval. As a policy, subject matter listed above, not Drug Enforcement Administration
result of your comments, we will make disposed of at the scheduled meeting,
any necessary adjustments to the burden may be carried over to the agenda of the [Docket No. DEA–392]
in our submission to OMB. following meeting.
Public Comment Procedures: Before By order of the Commission. Bulk Manufacturer of Controlled
including your address, phone number, Substances Application: Sigma Aldrich
Issued: June 8, 2016.
email address, or other personal Research Biochemicals, Inc.
William R. Bishop,
identifying information in your
comment, you should be aware that Supervisory Hearings and Information
Officer.
ACTION: Notice of application.
your entire comment—including your
personal identifying information—may [FR Doc. 2016–14045 Filed 6–9–16; 4:15 pm]
BILLING CODE 7020–02–P
DATES: Registered bulk manufacturers of
be made publicly available at any time. the affected basic classes, and
While you can ask us in your comment applicants therefore, may file written
to withhold your personal identifying comments on or objections to the
information from public review, we INTERNATIONAL TRADE
COMMISSION issuance of the proposed registration in
cannot guarantee that we will be able to accordance with 21 CFR 1301.33(a) on
do so. [USITC SE–16–020] or before August 12, 2016.
BSEE Information Collection
Clearance Officer: Nicole Mason (703) Sunshine Act Meeting ADDRESSES: Written comments should
787–1607. be sent to: Drug Enforcement
AGENCY HOLDING THE MEETING: United Administration, Attention: DEA Federal
Dated: June 3, 2016. States International Trade Commission. Register Representative/ODW, 8701
Robert W. Middleton,
TIME AND DATE: June 22, 2016 at 11:00 Morrissette Drive, Springfield, Virginia
Deputy Chief, Office of Offshore Regulatory a.m. 22152.
Programs.
PLACE: Room 101, 500 E Street SW.,
[FR Doc. 2016–13862 Filed 6–10–16; 8:45 am]
Washington, DC 20436, Telephone: SUPPLEMENTARY INFORMATION: The
BILLING CODE 4310–VH–P
(202) 205–2000. Attorney General has delegated her
authority under the Controlled
STATUS: Open to the public.
Substances Act to the Administrator of
INTERNATIONAL TRADE MATTERS TO BE CONSIDERED: the Drug Enforcement Administration
COMMISSION 1. Agendas for future meetings: None. (DEA), 28 CFR 0.100(b). Authority to
2. Minutes. exercise all necessary functions with
[USITC SE–16–019] 3. Ratification List. respect to the promulgation and
4. Vote in Inv. Nos. 701–TA–541 and implementation of 21 CFR part 1301,
Sunshine Act Meeting 731–TA–1284 and 1286 (Final) (Cold- incident to the registration of
AGENCY HOLDING THE MEETING: United Rolled Steel Flat Products from China manufacturers, distributors, dispensers,
States International Trade Commission. and Japan). The Commission is importers, and exporters of controlled
currently scheduled to complete and file substances (other than final orders in
TIME AND DATE: June 16, 2016 at 11:00
its determinations and views of the connection with suspension, denial, or
a.m.
Commission on July 5, 2016. revocation of registration) has been
PLACE: Room 101, 500 E Street SW., 5. Outstanding action jackets: None.
Washington, DC 20436, Telephone: redelegated to the Deputy Assistant
In accordance with Commission Administrator of the DEA Office of
(202) 205–2000. policy, subject matter listed above, not
STATUS: Open to the public.
Diversion Control (‘‘Deputy Assistant
disposed of at the scheduled meeting, Administrator’’) pursuant to section 7 of
MATTERS TO BE CONSIDERED: may be carried over to the agenda of the 28 CFR part 0, appendix to subpart R.
1. Agendas for future meetings: None. following meeting.
2. Minutes. In accordance with 21 CFR
By order of the Commission. 1301.33(a), this is notice that on
3. Ratification List.
4. Vote in Inv. No. 731–TA–1071 Issued: June 8, 2016. February 1, 2016, Sigma Aldrich
(Second Review) (Alloy Magnesium William R. Bishop, Research Biochemicals, Inc., 1–3
from China). The Commission is Supervisory Hearings and Information Strathmore Road, Natick, Massachusetts
currently scheduled to complete and file Officer. 01760–2447 applied to be registered as
its determination and views of the [FR Doc. 2016–14044 Filed 6–9–16; 4:15 pm] a bulk manufacturer of the following
Commission on June 30, 2016. BILLING CODE 7020–02–P basic classes of controlled substances:

Controlled substance Schedule

Cathinone (1235) ......................................................................................................................................................................................... I
Methcathinone (1237) .................................................................................................................................................................................. I
Mephedrone (4-Methyl-N-methylcathinone) (1248) .................................................................................................................................... I
Aminorex (1585) .......................................................................................................................................................................................... I
srobinson on DSK5SPTVN1PROD with NOTICES

Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... I
Lysergic acid diethylamide (7315) ............................................................................................................................................................... I
Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I
4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I
4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I
4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. I
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I
3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I

VerDate Sep<11>2014 20:48 Jun 10, 2016 Jkt 238001 PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 E:\FR\FM\13JNN1.SGM 13JNN1

Document Created: 2018-02-08 07:39:57
Document Modified: 2018-02-08 07:39:57

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 16, 2016 at 11:00 a.m.
FR Citation		81 FR 38217